Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer

被引：0
作者：
A J Weickhardt
D S Williams
C K Lee
F Chionh
J Simes
C Murone
K Wilson
M M Parry
K Asadi
A M Scott
C J A Punt
I D Nagtegaal
T J Price
J M Mariadason
N C Tebbutt
机构：
[1] Ludwig Institute for Cancer Research,Department of Anatomical Pathology
[2] Melbourne – Austin Branch,undefined
[3] Austin Health,undefined
[4] National Health and Medical Research Council Clinical Trials Centre,undefined
[5] University of Sydney,undefined
[6] Academic Medical Center,undefined
[7] University of Amsterdam,undefined
[8] Radboud University Nijmegen Medical Center,undefined
[9] The Queen Elizabeth Hospital and University of Adelaide,undefined
[10] Ludwig Oncology Unit,undefined
[11] Austin Hospital,undefined
来源：
British Journal of Cancer | 2015年 / 113卷
关键词：
bevacizumab; VEGF; colorectal cancer; biomarkers; prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：37 / 45
页数：8
相关论文
共 50 条
  • [21] Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer
    Sachi Morita
    Keisuke Uehara
    Goro Nakayama
    Takashi Shibata
    Tomoyo Oguri
    Megumi Inada-Inoue
    Tomoya Shimokata
    Mihoko Sugishita
    Ayako Mitsuma
    Yuichi Ando
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 71 : 405 - 411
  • [22] Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer
    Morita, Sachi
    Uehara, Keisuke
    Nakayama, Goro
    Shibata, Takashi
    Oguri, Tomoyo
    Inada-Inoue, Megumi
    Shimokata, Tomoya
    Sugishita, Mihoko
    Mitsuma, Ayako
    Ando, Yuichi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 405 - 411
  • [23] Comparative Analysis of Vascular Endothelial Growth Factor-A, C, D Expression in Colorectal Cancer with Liver Metastasis
    Chun, Kwang-Sik
    Lee, Kyung-Ha
    Song, In-Sang
    Kim, Ji-Yeon
    Kim, Je-Ryong
    Ahn, Moon-Sang
    Lee, Sang-Il
    Park, Jong-Hyun
    Choi, Song-E
    Kang, Dae-Young
    Song, Kyu-Sang
    [J]. JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2009, 76 (05): : 307 - 315
  • [24] The prognostic significance of vascular endothelial growth factor-D expression in colorectal cancer: a meta-analysis
    Lin, Chun-Lin
    Zhu, Guang-Wei
    Huang, Yong-Jian
    Zheng, Wei
    Yang, Shu-Gang
    Cheng, Zhi-Bin
    Ye, Jian-Xin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11953 - 11963
  • [25] Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer
    Minagawa, N
    Nakayama, Y
    Hirata, K
    Onitsuka, K
    Inoue, Y
    Nagata, N
    Itoh, H
    [J]. ANTICANCER RESEARCH, 2002, 22 (05) : 2957 - 2963
  • [26] The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients
    Bendardaf, Riyad
    El-Serafi, Ahmed
    Syrjanen, Kari
    Colland, Yrjo
    Pyrhonen, Seppo
    [J]. LIBYAN JOURNAL OF MEDICINE, 2017, 12
  • [27] Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer
    Ohno, M
    Nakamura, T
    Kunimoto, Y
    Nishimura, K
    Chung-Kang, C
    Kuroda, Y
    [J]. ONCOLOGY REPORTS, 2003, 10 (04) : 939 - 943
  • [28] Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: From the biology to the clinic
    Ranieri, Girolamo
    Patruno, Rosa
    Ruggieri, Eustachio
    Montemurro, Severino
    Valerio, Paolo
    Ribatti, Domenico
    [J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (16) : 1845 - 1857
  • [29] Prognostic Importance of Vascular Endothelial Growth Factor-A Expression and Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancer
    Smerdel, Maja Patricia
    Waldstrom, Marianne
    Brandslund, Ivan
    Steffensen, Karina Dahl
    Anderson, Rikke Fredslund
    Jakobsen, Anders
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (04) : 578 - 584
  • [30] Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab
    A K Koutras
    A G Antonacopoulou
    A G Eleftheraki
    F-I Dimitrakopoulos
    A Koumarianou
    I Varthalitis
    F Fostira
    J Sgouros
    E Briasoulis
    E Bournakis
    D Bafaloukos
    I Bompolaki
    E Galani
    K T Kalogeras
    D Pectasides
    G Fountzilas
    H P Kalofonos
    [J]. The Pharmacogenomics Journal, 2012, 12 : 468 - 475
12345